FEMTHERAPEUTICS
DEAD

Serial Number

79372049

Owner

FemTherapeutics Inc.

Attorney

James R Menker

Filing Date

Apr 21, 2023

Add to watchlist:

No watchlists yet
View on USPTO

FEMTHERAPEUTICS Trademark

Serial Number: 79372049

FEMTHERAPEUTICS is a trademark filed by FemTherapeutics Inc. on April 21, 2023. The trademark is classified under Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

FemTherapeutics Inc.

221-3220 av. Ridgewood

Entity Type: 03

Trademark Details

Filing Date

April 21, 2023

Registration Date

Not Registered

Goods & Services

3D printing design services, namely, custom 3D printing for others; medical research; providing information about medical research

3D biomedical imaging services; fitting of prosthetic devices; professional consultancy in the field of medical surgery and orthopaedics; professional consultancy in the field of medical care, namely, the use of medical technology to provide medical care; providing medical information in the field of women's health and contraception

Orthopaedic implants comprised of artificial materials; pessaries; surgical implants comprised of artificial materials for replacing human tissue; vaginal dilators; pessary applicators sold empty for medical use; prosthetic implants comprised of artificial materials; cervical dilators being vaginal dilators; vaginal stents

3D printing for others; custom manufacture of medical instruments; custom manufacture of prosthetics; parts molding services for medical equipment

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 19, 2026 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Jan 30, 2026 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 30, 2026 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 28, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 3, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 3, 2025 OPNR
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jan 30, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 30, 2025 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 16, 2024 GNFN
FINAL REFUSAL E-MAILED
Jul 16, 2024 GNFR
FINAL REFUSAL WRITTEN
Jul 16, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 9, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 9, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 9, 2024 TROA
REFUSAL PROCESSED BY IB
May 8, 2024 RFNT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 8, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 8, 2024 GNRT
NON-FINAL ACTION WRITTEN
Apr 8, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 13, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 13, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 13, 2024 TROA
REFUSAL PROCESSED BY IB
Feb 27, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 8, 2024 RFCS
REFUSAL PROCESSED BY MPU
Feb 8, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 24, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jan 23, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 19, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 20, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 16, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 15, 2023 REPR